Lactose Coated Granules are pharmaceutical excipient-based granules consisting of a lactose core or lactose-rich granulated structure with a controlled surface coating. Coating can be used to modify the surface characteristics, handling properties, protection, compatibility, or functional performance of granules according to the intended formulation and manufacturing process. Lactose is widely used as a pharmaceutical excipient because of its established role as a diluent, bulking agent, and carrier in pharmaceutical formulations.
Lactose is available in different forms, including lactose monohydrate and anhydrous lactose. USP-NF maintains separate monographs for these forms. Lactose Monohydrate is defined as the monohydrate form of O-β-D-galactopyranosyl-(1→4)-α-D-glucopyranose.
Coated lactose granules can be developed using different coating approaches depending on the intended application. Pharmaceutical research has demonstrated the use of fluid-bed coating for modifying lactose carrier particle surfaces. Such processing can change surface roughness and other physical characteristics of lactose particles, which may influence formulation performance.
Lactose Coated Granules are designed for applications where a controlled and reproducible granulated excipient is preferred over an uncoated powder or conventional granule. The lactose core can provide the physical and functional characteristics associated with lactose, while the coating layer can be selected and controlled according to the required formulation objective.
The coating system is product-specific. Depending on the formulation, the coating may be designed to provide surface modification, protection, improved handling, altered wetting characteristics, compatibility with other formulation components, or a defined functional barrier. Therefore, coating material, coating level, coating thickness, and performance characteristics should be specified according to the actual finished product specification rather than assumed from the term “coated granules.”
Research has also demonstrated precision coating and surface modification of lactose carrier particles. In one study, lactose particles were spray-coated with micronized lactose to modify their surface characteristics, demonstrating that coating can be used to engineer lactose particle surfaces.
The lactose form used in coated granules is important because lactose monohydrate and anhydrous lactose have different chemical forms and water characteristics.
Lactose Monohydrate contains one molecule of water of crystallization, while anhydrous lactose does not. USP-NF recognizes Lactose Monohydrate as a separate compendial material.
For product development, the lactose form should therefore be clearly identified in the product specification and supporting documentation. The CAS number, molecular formula, molecular weight, moisture characteristics, and applicable compendial requirements should correspond to the actual lactose form used.
Coating is an important pharmaceutical processing technique used to modify the external surface of particulate materials. Granules can be coated using techniques such as fluid-bed coating, spray coating, or other controlled particle-coating technologies.
During a coating process, coating formulation, spray rate, atomization conditions, drying conditions, coating level, and process endpoint can influence the resulting granule characteristics. Research on granule coating has shown that coating-layer thickness and coating composition can affect the monitoring and characterization of the coating process.
For Lactose Coated Granules, the finished product should therefore be evaluated using appropriate physical and functional parameters. Depending on the intended application, these may include particle-size distribution, surface morphology, bulk density, tapped density, flowability, moisture content, coating weight gain, coating uniformity, and other product-specific quality attributes.
Particle size is an important consideration for pharmaceutical granules. Lactose granules can be characterized using parameters such as D10, D50, and D90, together with particle morphology and surface characteristics.
Research involving granulated lactose has demonstrated that granule size, surface roughness, density, and flowability can influence formulation performance.
For coated granules, particle-size distribution should be evaluated both before and after coating where appropriate. Excessive agglomeration, coating-related enlargement, or inconsistent coating distribution can affect downstream processing. A controlled granulation and coating process helps maintain reproducible material characteristics.
The coating layer of Lactose Coated Granules can be used to modify the surface of the lactose-based particle. Surface engineering can influence interactions between granules and other formulation components.
Published pharmaceutical research has demonstrated that fluid-bed coating can modify lactose carrier surfaces and alter surface roughness. The study evaluated different coating levels and showed relationships between surface characteristics and formulation performance.
This makes coated lactose granules useful where surface properties need to be controlled more precisely than with an untreated lactose material.
Lactose Coated Granules may be considered for pharmaceutical formulation development where a coated, particulate lactose excipient is required.
Potential formulation applications include:
The exact application depends on the coating composition, coating level, lactose grade, particle-size distribution, and finished-product performance requirements.
Important quality characteristics for Lactose Coated Granules may include:
Not every parameter is a universal compendial requirement for coated granules. Finished-product specifications should therefore be based on the actual manufacturing process and validated product requirements.
Lactose Coated Granules should be manufactured under controlled pharmaceutical processing conditions. Critical process parameters may include granulation conditions, coating suspension or solution characteristics, spray rate, atomization, drying conditions, coating weight gain, and process endpoint.
Quality control should verify the identity and relevant characteristics of the lactose starting material and the finished coated granules. Depending on the product specification, testing may include identification, loss on drying or moisture, residue on ignition, particle-size distribution, density, flow properties, coating uniformity, and other validated tests.
Because coated granules are finished processed materials, coating-specific characteristics should not be represented as universal lactose monograph specifications. Parameters such as coating thickness, coating weight gain, dissolution profile, release duration, and coating-polymer concentration should only be stated when supported by the actual product specification or Certificate of Analysis.
Lactose is an established pharmaceutical excipient used in a broad range of formulation processes. Granulation and coating can further modify the physical characteristics of lactose-based particulate materials.
The use of granulated and coated lactose allows formulation developers to work with engineered particle characteristics rather than relying solely on the properties of the original lactose powder. Research has examined lactose granules in relation to particle size, morphology, surface properties, flowability, and pharmaceutical processing performance.
Lactose Coated Granules can therefore be positioned as a specialized pharmaceutical excipient format for applications requiring controlled particulate characteristics and surface modification.
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.1% |
| Individual Impurity | NMT 0.5% |
| Water Content | NMT 0.5% |